New Delhi: The Narendra Modi authorities on Tuesday knowledgeable the Parliament that almost 188 crore COVID vaccine doses are required to inoculate the 18-plus inhabitants as a part of the continued mass vaccination drive to fight COVID-19.
The govt mentioned that the projected 18-plus inhabitants within the nation is 94 crore and due to this fact, the whole requirement of COVID-19 vaccine doses for the beneficiaries on this age group is 188 crore.
However, the quantity might cut back if, sooner or later, single-dose vaccines are accredited and used, the federal government advised Parliament.
In a written reply to a query within the Rajya Sabha on whether or not the current COVID vaccine manufacturing companies have the capability to produce the required amount, Minister of State for Health Bharati Praveen Pawar mentioned it’s estimated that round 1.87 billion (187 crore) doses might be obtainable between January and December 2021.
In addition, a couple of vaccines beneath growth may obtain approval and could also be obtainable to be used to inoculate the eligible inhabitants, she added.
In a separate written reply, Pawar mentioned the value of the COVID vaccines declared by the 2 home producers for procurement by personal hospitals is Rs 600 for Covishield and Rs 1,200 for Covaxin. In addition, Rs 948 is the value declared for Sputnik V, which is presently imported within the nation.
The authorities has fastened a most service cost of Rs 150 per dose over and above the value of the vaccines for administration at personal COVID-19 vaccination centres (CVCs). However, the vaccines proceed to be supplied without cost to all eligible beneficiaries on the authorities CVCs.
The producers are free to repair the value of the vaccines for procurement by personal hospitals. However, the identical has to be declared in a clear method, which has been completed by the companies, the minister mentioned.
Replying to one other query, Pawar knowledgeable that the COVID vaccines presently obtainable within the nation should not have VVMs (Vaccine Vial Monitors). The storage and transportation of the vaccines from the producer to the positioning of administration is ensured in a temperature-controlled atmosphere at 2-8 levels Celsius.
The VVM is manufactured by a single offshore producer and requires end-point research at varied period to finalise the kind to be used on every vaccine.
In view of the worldwide urgency to use COVID vaccines upon growth, the requirement of a really excessive amount of VVMs and the restricted manufacturing capability, the vaccines are getting used with out VVMs internationally, the minister mentioned.
A strong chilly chain community of round 29,000 cold-chain factors, together with insulated or refrigerated vaccine vans, is used to make sure the storage and transport of the vaccines in a temperature-controlled atmosphere.Â
The storage temperature can be being monitored on a real-time foundation to be sure that the vaccines will not be uncovered past the beneficial storage temperature, the reply said.Â
 Live TV
